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doi:10.1Objective: Interstage mortality has been reported in 10% to 25% of hospital survivors after single-ventricle
palliation. The purpose of this study was to examine the impact of feeding modality at discharge after
single-ventricle palliation on interstage mortality.
Methods: We conducted a retrospective review of all neonates undergoing single-ventricle palliation from
January 2003 to January 2010. A total of 334 patients (90%) survived to hospital discharge, comprising the
study group. Preoperative, operative, and postoperative variables were examined, including feeding method
at discharge. Multivariate Poisson regression models were constructed to estimate the relative risk of interstage
mortality.
Results: Of 334 patients, 56 (17%) underwent gastrostomy tube  Nissen. There was a statistically significant
increase in interstage mortality for patients who underwent gastrostomy tube  Nissen compared with patients
who did not (relative risk, 2.38; 95% confidence interval, 1.05–5.40; P¼ .04]). Of the 278 patients whowere not
fed via a gastrostomy tube  Nissen, 190 (68%) were fed with nasogastric feedings and 88 (32%) were fed
entirely by mouth. There was no difference in interstage mortality between these 2 groups (relative risk,
0.92; 95% confidence interval, 0.31–2.73; P ¼ .89).
Conclusions: Neonates undergoing single-ventricle palliation who require gastrostomy tube Nissen are at an
increased risk of interstagemortality. The need for gastrostomy tubeNissen in this populationmay be amarker
for other unmeasured comorbidities that place them at an increased risk of interstage mortality. Discharge with
nasogastric feeds does not increase the risk of interstage mortality. (J Thorac Cardiovasc Surg 2012;144:173-7)C
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DInterstage mortality has been shown in 10% to 25% of hospi-
tal survivors after single-ventricle palliative cardiac surgery.1-6
Respiratory infection,7,8 sepsis,5,8 coronary obstruction,9 aor-
tic arch obstruction,8,10 low cardiac output,5,8,11 arrhythmia,6
and sudden unexplained cardiac death6-8 have been
reported as potential causes. After single-ventricle pallia-
tion, patients frequently have difficulty feeding per os
(PO), which is often attributed to lack of preoperative feed-
ing, poor oromotor skills, gastroesophageal reflux, and con-
gestive heart failure, among other problems.12 Because of
these issues, alternativemethods of enteral feeding are com-
monly used, that is, nasogastric tube (NG), gastrostomy tube
(GT), or Nissen fundoplication and gastrostomy tube (Nis-
sen/GT). Limited data exist on the impact of these alterna-
tive feeding modalities on interstage mortality. Thus,
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The Journal of Thoracic and CaThe purpose of this study was to evaluate the association
of feeding route at the time of discharge with interstage
mortality after single-ventricle palliation. We hypothesized
that (1) patients who received a Nissen/GT would be at
a lower risk of interstage mortality because of protection
against aspiration-related death and that (2) there would
be no difference in mortality between PO and NG feeding
in patients.MATERIALS AND METHODS
Patient Population
We conducted a retrospective cohort study of all neonates (aged<30
days at time of surgery) undergoing a single-ventricle palliative procedure
(Norwood operation, pulmonary artery band, or modified Blalock–Taussig
shunt) from January 2003 to January 2010 at a single institution. A total of
372 total neonates were identified. Thirty-eight neonates who died after
single-ventricle palliation before hospital discharge were excluded from
further analysis. End points for our analysis were completion of a second
palliative operation (or in some cases a complete surgical repair) or death
before the second surgery. Therefore, 334 patientsmeeting entrance criteria
comprised the study group. This retrospective review was performed with
approval of the institutional review board at Children’s Healthcare of
Atlanta with waiver of informed consent.
Study Variables
Our primary outcome of interest was interstage mortality, defined as
death between hospital discharge after single-ventricle palliation and
second-stage procedure. Our primary predictor variable of interest was
feeding modality at time of discharge. We performed separate analysesrdiovascular Surgery c Volume 144, Number 1 173
TABLE 1. Underlying anatomic diagnoses (n ¼ 334)
Anatomic diagnosis
Percentage of
total study group
Hypoplastic left heart syndrome 31%
Tricuspid atresia 9%
Unbalanced atrioventricular canal 6%
Heterotaxy single-ventricle variant 6%
Double-inlet left ventricle 6%
Pulmonary atresia with a ventriculoseptal defect 10%
Pulmonary atresia with intact ventricular septum 15%
Tetralogy of Fallot 4%
Transposition of the great arteries with pulmonic
stenosis
6%
Other 7%
Abbreviations and Acronyms
CI ¼ confidence interval
GERD ¼ gastroesophageal reflux disease
GT ¼ gastrostomy tube
NG ¼ nasogastric tube
Nissen/
GT
¼ Nissen fundoplication and
gastrostomy tube
PO ¼ per os (oral)
RR ¼ risk ratio
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Dfor 1) those with a Nissen/GT versus those without a Nissen/GT and 2)
those discharged with any nasogastric (NG) feeds versus those discharged
with all PO feeds. For these analyses, the patients who received a GTalone
were included in the Nissen/GT group. The patients in the NG group in-
cluded those fed entirely with NG feeds and thosewhowere fed with hybrid
PO/NG feeds. Our primary covariates of interest were preoperative, oper-
ative, and postoperative variables that could affect interstage mortality.
Age, weight, prematurity,13 genetic abnormality,7 heterotaxy,7 arrhyth-
mia,6 and decreased systemic ventricular function14 were specifically in-
cluded in the multivariate analysis to control for known risk factors for
interstage death. Prematurity was defined as less than 37 weeks gestation.
Genetic abnormality was defined as dysmorphic appearance in the opinion
of a consulting geneticist (consult obtained if clinical suspicion was high)
or abnormal genetic testing. An arrhythmia was defined as any tachyar-
rhythmia or bradyarrhythmia that required medical intervention and
occurred before discharge. Single-ventricle function was described as de-
creased or normal on the basis of qualitative interpretation of the discharge
echocardiogram. Finally, although no standard algorithm for pursuing
a Nissen/GT exists at Children’s Healthcare of Atlanta, every patient
who underwent the procedure had clinically significant gastroesophageal
reflux disease (GERD) that failed medical therapy, plus failure to thrive
(31%) or aspiration (69%) as the primary indications for surgery. A GT
without a Nissen was only placed if no significant GERD was suspected.
All patients underwent an upper gastrointestinal fluoroscopy study before
the procedure, and 39% of patients received a pH probe (at the discretion
of the pediatric general surgeon and cardiothoracic surgeon).
Statistical Analysis
For each of our analysis groups, (1) Nissen/GT versus no Nissen/GTand
(2) any NG versus entirely PO, we first compared baseline categoric vari-
ables using chi-square tests and baseline continuous variables using t tests.
We then constructed multivariate Poisson regression models adjusting for
the covariates listed above to estimate the relative risk of interstage mortal-
ity for each comparison group. To assess whether there was a difference in
relative risk for those with or without a Norwood operation, we then per-
formed separate stratified analyses in these 2 populations. From the regres-
sion models, we calculated adjusted risk ratios (RRs) and 95% confidence
intervals (CIs). All analyses were performed using SAS Version 9.2 (SAS
Institute, Inc, Cary, NC). Data are expressed as mean values  standard
deviations.RESULTS
In this cohort study, 165 patients underwent a Norwood
operation, 17 patients underwent a pulmonary artery
band, and 152 patients underwent a Blalock–Taussig shunt.
The underlying anatomy of the study group is shown in
Table 1.174 The Journal of Thoracic and Cardiovascular SurgNissen/Gastrostomy Tube Versus No Nissen/
Gastrostomy Tube
Among the 334 study patients, 56 underwent a Nissen/
GTor GTalone (Nissen/GT in 42 andGTalone in 14). Com-
plete comparisons between these patients and all other
patients are shown in Table 2. The results of multivariate
analysis, constructed using previously published risk
factors for interstage mortality, are shown in Table 3. The
adjusted relative risk of interstage mortality for those pa-
tients with single-ventricle physiology with a Nissen/GT
versus those without a Nissen/GT was 2.38 (95% CI,
1.05–5.40; P¼ .04). In the stratified analyses, this estimated
relative risk of interstage mortality for those with a Nissen/
GT versus those without a Nissen/GT was similar in both
the Norwood group (RR, 2.24) and the non-Norwood group
(RR, 2.10).
Because of the unexpected finding of increased risk of in-
terstage mortality in the patients who underwent Nissen/
GT, we evaluated our inpatient post-Nissen experience.
Fifty-six (96%) of the 58 patients who underwent a Nis-
sen/GT survived to hospital discharge. One inpatient death
was remote from surgery and occurred during attempted op-
erative removal of a large pericardial clot. The other death
occurred within hours of Nissen/GT surgery and manifested
as a bradycardiac event followed by unsuccessful resuscita-
tion; no autopsy was performed. Other complications in-
cluded 1 failed Nissen wrap that was redone 5 months
after the original surgery, 1 prolonged intubation postoper-
atively, 3 procedures that were converted from laparoscopic
to open (thus with longer recovery time), and 3 gastrocuta-
neous fistulas. Of note, cardiac anesthesia was consulted for
all Nissen/GT procedures, and all patients recovered in the
cardiac intensive care unit. Fifty-one (88%) of the 58 pro-
cedures were performed laparoscopically.Nasogastric Tube Feeding Versus Entirely Oral
Feeding
Of the 278 patients who did not have a Nissen/GT, 190
(68%) were discharged from the hospital using at leastery c July 2012
TABLE 2. Nissen/gastrostomy tube or gastrostomy tube alone versus
no Nissen/gastrostomy tube: Patient characteristics
Nissen/
GT group
No Nissen/
GT group
P
value
Patient No. 56 (17%) 278 (83%)
Preoperative variables
Weight (kg) 3.0  0.5 3.1  0.5 .25
Genetic syndrome (N,%) 13 (23%) 37 (13%) .06
Prematurity (N,%) 6 (11%) 36 (13%) .64
Heterotaxy (N,%) 4 (7%) 17 (6%) .76
Operative variables
Age at surgery (mean  SD, d) 7  5 7  6 .68
Norwood procedure (N,%) 36 (64%) 129 (46%) .02
Pulmonary artery band (N,%) 0 (0%) 17 (6%) .06
Blalock–Taussig shunt (N,%) 20 (36%) 132 (48%) .11
Cardiopulmonary bypass operation
(N,%)
37 (66%) 148 (53%) .08
Cardiopulmonary bypass time
(mean  SD, min)
151  31 146  47 .44
Aortic crossclamp time (mean 
SD, min)
56  14 65  17 .003
Circulatory arrest (N,%) 21 (37%) 82 (30%) .24
Circulatory arrest time (mean 
SD, min)
6.4  8.2 5.8  7.6 .74
Delayed sternal closure (N,%) 25 (45%) 76 (27%) .01
Postoperative variables
Mechanical ventilation time (mean
 SD, h)
240  234 158  177 .01
ICU length of stay (mean  SD, d) 20  18 10  11 <.001
Hospital length of stay (mean 
SD, d)
39  21 17  15 <.001
Postoperative arrhythmia (N,%) 15 (27%) 66 (24%) .63
Decreased ventricular function at
discharge (N,%)
6 (10%) 25 (9%) .69
Interstage mortality (N,%) 9 (16.1%) 17 (6.1%) .02
ICU, Intensive care unit; SD, standard deviation.
TABLE 3. Multivariate analysis of interstage mortality risk
Relative risk (95% CI) P value
Nissen/GT or GT alone compared
with no Nissen/GT
2.38 (1.05–5.40)* .04
*Adjusted for age, weight, genetic syndrome, prematurity, heterotaxy, postoperative
arrhythmia, and decreased ventricular function at discharge.
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Dsome NG feeds, and the remaining 88 (32%) were dis-
charged feeding entirely PO. Table 4 lists the comparisons
between the 2 groups. Table 5 contains the results of the
multivariate analysis. There was no difference in interstage
mortality between the 2 groups; the adjusted relative risk of
interstage mortality for those patients with a single ventricle
without a Nissen/GT but with some NG feeds versus those
with all PO feeds was 0.92 (95%CI, 0.31–2.73; P¼ .89). In
the stratified analyses, this estimated relative risk of inter-
stage mortality for those with NG feeds versus those with
all PO feeds was similar in both the Norwood group (RR,
0.92) and the non-Norwood group (RR, 0.95).
There were 26 total interstage deaths among our 334 pa-
tients (7.8%), of whom 15 (58%) died after the Norwood
procedure and 11 (42%) died after the Blalock–Taussig
shunt (there were no cases of interstage death among the
17 patients with a pulmonary artery band). Seven patients
died while an inpatient or in the emergency department of
Children’s Healthcare of Atlanta, with the remaining 19The Journal of Thoracic and Capatients dying at home or at outside facilities. Of the 7 pa-
tients who died within our hospital system, 2 deaths were
attributed to complications from recrudescence of patho-
logic anatomy, specifically a restrictive atrial septum and
re-coarctation of the aorta in 2 patients with hypoplastic
left heart syndrome. Two other patients had a clotted Bla-
lock–Taussig shunt listed as the cause of death. A single pa-
tient died after presenting with severe dehydration due to
diarrhea caused by a rotaviral infection. The final 2 patients
presented to the emergency department in full arrest and did
not have a cause of death ascribed. As for the 19 patients
who died at home or at outside facilities, no firm cause of
death can be attributed for any of these children. No autop-
sies were performed. We know that 4 patients were status
post-Nissen/GT, 3 patients were status post-GT only, 3 pa-
tients were NG feeding at the time, 5 patients were feeding
entirely PO, and 4 patients had transitioned from NG tube
feeding to entirely feeding PO. The mean time period since
last clinic visit for these patients was 6.6 days (range, 1–23
days) with no new pathologic anatomy suspected on the ba-
sis of the documentation from those appointments.DISCUSSION
Feeding difficulties in newborns after congenital heart
surgery are common. Kogon and colleagues12 reviewed
their postoperative experience and found that 11% of new-
borns required a prolonged time to reach goal feeds, 45%
had difficulty transitioning to PO feeds, and 10% required
a surgical procedure, such as a Nissen or G-tube before
discharge. Of particular interest, the presence of a single
functional ventricle or a systemic to pulmonary artery shunt
was a risk factor for such a surgical procedure to facilitate
delivery of nutrition. With this in mind, the current study
examined neonates after single-ventricle palliation to
discern whether the method of feeding at discharge affected
interstage mortality.
We first compared patients who were discharged after
a Nissen/GT versus all other feeding modalities (NG tube
and PO feeding). Although a Nissen/GT has been shown
to hasten weight gain in patients with single-ventricle phys-
iology,15 limited data exist as to its effects on mortality in
this patient population. Our hypothesis was that the Nissen/
GTwould protect against interstage mortality by decreasing
aspiration-related deaths. Support for this supposition
comes from previous studies that concluded that a Nissen
fundoplication protects against aspiration in pediatricrdiovascular Surgery c Volume 144, Number 1 175
TABLE 4. Nasogastric feeding versus per os feeding: Patient
characteristics
NG
feeding
All PO
feeding
P
value
Patient No. 190 (68%) 88 (32%)
Preoperative variables
Weight (kg) 3.0  0.6 3.0  0.5 .87
Genetic syndrome (N,%) 26 (14%) 11 (12%) .79
Prematurity (N,%) 26 (14%) 10 (11%) .59
Heterotaxy (N,%) 13 (7%) 4 (5%) .45
Operative variables
Age at surgery (mean  SD, d) 7  6 7  6 .65
Norwood procedure (N,%) 100 (53%) 29 (33%) .002
Pulmonary artery band (N,%) 10 (5%) 7 (8%) .38
Blalock–Taussig shunt (N,%) 80 (42%) 52 (59%) .008
Cardiopulmonary bypass operation
(N,%)
115 (61%) 33 (37%) <.001
Cardiopulmonary bypass time
(mean  SD, min)
148  49 140  36 .03
Aortic crossclamp time (mean 
SD, min)
66  16 63  21 .53
Circulatory arrest (N,%) 60 (32%) 22 (25%) .26
Circulatory arrest time (mean 
SD, min)
5.8  8.4 5.9  4.9 .93
Delayed sternal closure (N,%) 59 (31%) 17 (19%) .04
Postoperative variables
Mechanical ventilation time (mean
 SD, h)
178  199 115  107 <.001
ICU length of stay (mean  SD, d) 11  13 7  6 <.001
Hospital length of stay (mean 
SD, d)
18  16 14  12 .02
Postoperative arrhythmia (N,%) 49 (26%) 17 (19%) .24
Decreased ventricular function at
discharge (N,%)
21 (11%) 4 (5%) .08
Interstage mortality (N,%) 12 (6.3%) 5 (5.4%) .78
ICU, Intensive care unit; SD, standard deviation.
TABLE 5. Multivariate analysis of interstage mortality risk
Relative risk (95% CI) P value
NG feeding compared with all
PO feeding
0.92 (0.31–2.73)* .89
*Adjusted for age, weight, genetic syndrome, prematurity, heterotaxy, postoperative
arrhythmia, and decreased ventricular function at discharge.
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Dpatients in general.16-18 In our study, however, there was an
increased relative risk of interstage mortality in neonates
who underwent a Nissen/GT compared with neonates who
did not. Although none of the interstage mortalities were
believed to be due to the Nissen procedure itself, we cannot
state this with certainty because the majority of our patients
died suddenly at home without a subsequent autopsy.
Instead, we are left to speculate that the need for a Nissen/
GT in this patient population may be a marker for increased
interstage mortality risk rather than a contributing factor
itself. In other words, there may be important unmeasured
factors in the Nissen/GT group that increase their risk for
interstage mortality. Support for this hypothesis comes from
the fact that the procedure does nothing to negatively alter
known risk factors for interstage mortality (eg, arrhythmias,
genetic syndrome, and unbalanced hemodynamics) and is
safe to perform in and of itself (96% survival to discharge
and low complication rate). However, the increased
occurrence of interstage mortality in the Nissen/GT cases176 The Journal of Thoracic and Cardiovascular Surgremains unnerving. Previous authors have sought to modify
interstage mortality by standardization of outpatient care
through home-monitoring programs or single-ventricle
clinics.19-21 Our institutional standard includes frequent
scheduled outpatient cardiology appointments and home
health nursing assessments. We do not currently rely on data
collected by families in our complex patient demographic.
Regardless, although the Nissen/GT remains safe to perform
(see discussion below) and often the only alternative in
patients with recalcitrant GERD with aspiration or failure
to thrive, these patients might also represent a select
subpopulation who could benefit from more extensive
monitoring.
Our data show that with proper multispecialty support,
a Nissen/GT is a safe procedure to perform in patients
with single-ventricle physiology. This conclusion is congru-
ent with previous studies detailing successful surgical out-
comes in other fragile patient populations.22 At Children’s
Healthcare of Atlanta, all patients receive a presurgical con-
sult from cardiac anesthesia and postoperative management
in the cardiac intensive care unit. A laparoscopic approach
is used in the majority of cases; 88% of patients received
this minimally invasive technique in our study. Compared
with an open technique, the benefits of the laparoscopic pro-
cedure are decreased recovery time, earlier postoperative
feeding, reduced incidence of wound infections, and de-
creased complications.11,23
The current study also examined neonates after single-
ventricle palliation who were discharged with NG feedings
versus those discharged feeding entirely PO. Home NG
feeding has been shown to be of limited risk in children
(even in high-risk patients)24,25 but has never been
specifically evaluated in single-ventricle neonates. In the
current study, there was no difference in interstage mortality
between the 2 groups. This may be related in part to the
teaching and support services available at Children’s
Healthcare of Atlanta. Parents of patients discharged with
NG feeding receive standardized teaching regarding tube
replacement, feeding pump troubleshooting, formula mix-
ing, and symptoms of feeding intolerance. The format for
this teaching includes an instructional video, an instruc-
tional booklet, discharge classes, and one-on-one teaching
with the nursing staff. Parents are also taught to adjust to
progress. For example, in a child expected to rapidly transi-
tion to all PO feedings and being discharged with PO/NG
hybrid feeds, instructions are that after 48 hours of all PO
feedings, the parents could remove the NG tube. Withery c July 2012
Hebson et al Congenital Heart Diseasesimilar support in place, we believe that our data demon-
strate that discharge with NG feeds does not increase the
risk of interstage mortality compared with all PO feeding.
Limitations to this study include those inherent to any ret-
rospective review. Furthermore, limited patient information
in some cases prevented ancillary data from being pre-
sented. Specifically, we do not know the cause of interstage
death in many cases (due to death at home or other hospitals
and lack of autopsies). We therefore cannot completely rule
out complications from a Nissen/GT as contributive. Fi-
nally, it is possible that the lack of difference in mortality,
between the NG tube and PO feeding groups, is due to inad-
equate power (ie, a type II error). Although our analyses
suggest that NG tube feeding is safe in this population, large
multicenter studies are warranted in an effort to replicate
these findings.C
H
DCONCLUSIONS
Neonates with single-ventricle palliative cardiac opera-
tions requiring a Nissen/GT have an increased incidence
of initial interstage mortality. The Nissen/GT most likely
serves as a marker for increased occurrence rather than
a contributive factor itself. Regardless, although a Nissen/
GT remains indicated in patients who have significant
GERD plus aspiration or failure to thrive, closer scrutiny
of the progress of these particular patients should be consid-
ered. For patients who do not require a Nissen/GT, dis-
charge with nasogastric feeds does not seem to increase
the risk of interstage mortality compared with infants feed-
ing entirely PO.
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